Contents

Current Pharmaceutical Design, Volume 15 - Number 23

Editorial [Hot Topic: Recombinant Immunotoxins – The Next Generation (Executive Editor: Stefan Barth)]

, 15(23): 2650 - 2651

Stefan Barth


DOI: 10.2174/138161209788923912




Recombinant Immunotoxins for the Treatment of Chemoresistant Hematologic Malignancies

, 15(23): 2652 - 2664

Robert J. Kreitman


DOI: 10.2174/138161209788923949




Ribonucleases and ImmunoRNases as Anticancer Drugs

, 15(23): 2665 - 2675

S. M. Rybak, M. A.E. Arndt, T. Schirrmann, S. Dubel and J. Krauss


DOI: 10.2174/138161209788923921




Development of Novel, Highly Cytotoxic Fusion Constructs Containing Granzyme B: Unique Mechanisms and Functions

, 15(23): 2676 - 2692

M. G. Rosenblum and S. Barth


DOI: 10.2174/138161209788923958




Immunokinases, a Novel Class of Immunotherapeutics for Targeted Cancer Therapy

, 15(23): 2693 - 2699

Mehmet Kemal Tur, Inga Neef, Gernot Jager, Andreas Teubner, Michael Stocker, Georg Melmer and Stefan Barth


DOI: 10.2174/138161209788923877




Improved Immunotoxins with Novel Functional Elements

, 15(23): 2700 - 2711

C. Hetzel, C. Bachran, M K. Tur, H. Fuchs and M. Stocker


DOI: 10.2174/138161209788923930




Fcγ Receptor 1 (CD64), a Target Beyond Cancer

, 15(23): 2712 - 2718

T. Thepen, M. Huhn, G. Melmer, M. K. Tur and S. Barth


DOI: 10.2174/138161209788923967




Targeting Phosphatidylserine in Anti-Cancer Therapy

, 15(23): 2719 - 2723

Heidi Kenis and Chris Reutelingsperger


DOI: 10.2174/138161209788923903




Nanocarriers in Ocular Drug Delivery: An Update Review

, 15(23): 2724 - 2750

Sheetu Wadhwa, Rishi Paliwal, Shivani Rai Paliwal and S. P. Vyas


DOI: 10.2174/138161209788923886




Vitamin D Deficiency: The Invisible Accomplice of Metabolic Endotoxemia?

, 15(23): 2751 - 2758

Paul Lee and Lesley V. Campbell


DOI: 10.2174/138161209788923895




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science